A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A randomized placebo-controlled study to evaluate the efficacy of PRX-03140 in subjects with
Alzheimer's Disease receiving a stable dose of donepezil. The study consists of a 26-week
double-blind treatment period.